News

Results Found (507)
July 6, 2008
Orangenhaine Weichen Biotech-Labors (German)
June 22, 2008
RNA Engineering can combat desease

Research that helps control errors in gene expression as a safer and more effective alternative to conventional drugs has won from Prof. Hermona Soreq, Dean of the Hebrew University Science Faculty one of this year's Kaye Innovation...

June 19, 2008
The Science of Money (Hebrew)

Nava Swersky Sofer aims to turn the academic wisdom of Hebrew University researchers the into money. This year revenues reached $50 million, and the future looks promising.   

June 17, 2008
Les Ecos: Le Talmud au secours de la hi-tech (French)
June 12, 2008
Invention to prevent surgical adhesions wins Kaye Award

A material designed to prevent adhesions following surgery, patented by Yissum, has won for Hebrew University Prof. Daniel Cohn of the Casali Instititue of Applied Chemistry first prize in this year's Kaye Awards for Innovation. The awards were...

June 11, 2008
Yissum Spin-off Morria Biopharmaceuticals Plc Announces Regulatory Approval...

Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on the development of novel anti-inflammatory drugs, today announced that it has obtained regulatory approval from the South African Medicines Control Council (MCC) to initiate a...

June 6, 2008
Jerusalem Post Health Scan: BETTER SALIVA TESTING

A novel device that enhances the diagnostic value of saliva has been produced by Hebrew University researchers. The disposable device clears whole saliva from its major protein constituent - alpha-amylase - to enable the detection of various...

June 4, 2008
Synthetic molecules may harbour new family of anti-cancer drugs

Two researchers at Hebrew University of Jerusalem have designed synthetic molecules that may have future implications for the development of a new family of anti-cancer drugs.

June 4, 2008
Tech Transfer eNews: Innovation of the Week: Yissum introduces device that...

Yissum, the technology transfer company of the Hebrew University of Jerusalem, introduced a novel device that enhances the diagnostic value of saliva. 

June 4, 2008
Hebrew U. researchers win award for cancer therapy

Dr. Arie Dagan and Prof. Shimon Gatt have developed molecules that kill cancers without affecting normal tissue. The technology is patented and commercialized by Yissum, the Technology Transfer Company of the Hebrew University.

June 2, 2008
Yissum on Biotech Finances (French)

Où Va Le Biopartnering Franco-Israélien ?

June 1, 2008
The existential dilemma of Israeli Biotech

A point of view on Israel's Biotech industry by Start Up Magazine